The University Of Maryland Department Of Medicine and the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC), located in Baltimore, MD, are recruiting for a full-time, Genetic Counselor.
Working alongside a renowned multidisciplinary team of Hematology/Oncology and oncology sub-specialty providers, the successful candidate will have responsibility for provision of genetic counseling services at two locations. Clinical services are provided in a hybrid model (virtual & in person format).
Genetic Counselors at the University of Maryland are Instructors and active in the University Of Maryland School Of Medicine’s Masters in Genetic Counseling Training Program. In addition to teaching and supervision of trainees in Genetic Counseling, our Genetic Counselors participate in teaching and training of medical students, residents, and fellows and have opportunities to collaborate in scholarly activities.
Education and Additional Requirements:
Master’s degree from a graduate program accredited by the Accreditation Council for Genetic Counseling (ACGC)
Board certified or board eligible by the American Board of Genetic Counseling
Certification and ongoing certification by the American Board of Genetic Counseling required for continued employment
Applicants with at least two to three years of relevant experience strongly preferred
Evidence of strong case management and independent critical thinking skills
The University of Maryland, Baltimore is an Equal Opportunity/Affirmative Action Employer. Minorities, women, individuals with disabilities, and protected veterans are encouraged to apply
When applying, please submit a current CV, a brief statement summarizing clinical and research interests, and names of three references. For questions following your application, please email firstname.lastname@example.org
The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) is a joint program of the University of Maryland School of Medicine and the University of Maryland Medical System. In 2008, UMGCC was named a National Cancer Institute (NCI)-designated cancer center, one of only 64 such centers in the country. UMGCCC is also ranked among the nation's 50 top cancer centers by U.S. News and World Report.
Within the School of Medicine and the other UMB schools, UMGCCC serves as the umbrella for all cancer-related activities on campus. Cancer Center members have academic appointments in various clinical and basic science departments of the School of Medicine and the schools of pharmacy, dentistry, social work, and nursing. Activities of the Cancer Center include basic and translational cancer research, student and house officer teaching, and a strong focus on new therapies in both an inpatient 46-bed unit and outpatient setting. The bone marrow transplant unit, on the 9th floor of the Gudelsky Tower, comprises 16 private rooms along with nursing and staff support space. In addition to full-time attending services on medical oncology and hematology, Cancer Ce...nter members participate in multidisciplinary clinical programs centered around specific cancers (e.g., breast, thoracic, genitourinary, gynecologic, head and neck, gastroenterologic and hematologic malignancies) with specialists from surgical and radiation oncology to provide integrated care for the cancer patient.
The UMGCCC has substantial NIH funding. The center is a strong participant in new drug development and trials, and is a member of several national cooperative groups. UMGCCC has a historic and sustained track record of clinical trials in human cancer. In FY 2008, 1,030 patients were accrued to clinical trials across UMGCCC and its affiliates. African Americans represent more than 40 percent of our patients, and nearly half of them take part in clinical trials at our Cancer Center. The Cancer Center has also established strong translational research programs in experimental therapeutics, hormone responsive cancers, molecular biology and genetics, viral oncology, tumor immunology, and cancer prevention and control. Cancer Center members have a strong commitment to intra- and inter-institutional cooperative cancer research.